NCT00292760
- Conditions
- Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
Not specified
Clinical trial condition
Leukemia, B-Cell
Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.
121 public trials
28 recruiting studies
Leukemia, B-Cell trial results
NCT00783588
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
NCT00779883
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
NCT05362773
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Chronic Disease, +37 more
- Locations
-
- Colorado Blood Cancer Network Denver, Colorado, United States
- University of Maryland, Greenbaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- START - Midwest Grand Rapids, Michigan, United States
Active, Not Recruiting
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
NCT05589896
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
- Locations
-
- City of Hope Duarte, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University - Winship Cancer Institute Atlanta, Georgia, United States
- Henry Ford Cancer Institute Detroit, Michigan, United States
Active, Not Recruiting
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
NCT03774654
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Active, Not Recruiting
CD22 Redirected Autologous T Cells for ALL
NCT02650414
- Conditions
- B Cell Leukemias, B Cell Lymphomas, Hematologic Diseases, +13 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Active, Not Recruiting
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
NCT03162536
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
- Locations
-
- Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
- UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
- Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
- University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
Active, Not Recruiting
A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
NCT01683279
- Conditions
- B Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States
Active, Not Recruiting
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
NCT03573700
- Conditions
- Acute Lymphoblastic Leukemia, Refractory, Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, +15 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States